
Global M&A trends in health industries: 2025 mid-year outlook
The prospect of tariffs, pricing reforms and longer approval times will test the resolve of health industries dealmakers in the second half of 2025.
The prospect of tariffs, pricing reforms and longer approval times will test the resolve of health industries dealmakers in the second half of 2025.
Discover how AI is revolutionising manufacturing by boosting productivity, cutting costs, and driving innovation. Explore key insights from 400+ global executives.
Health industries dealmakers gear up for a more favourable M&A environment in 2025.
The healthcare industry is evolving into a dynamic ecosystem. Patients, practitioners and industry players all stand to benefit.
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
A comprehensive introductory guide to Taiwan’s healthcare system and its biopharma and medical device sectors
SAP S/4HANA and provides the pharma and life sciences industry with advanced applications, analytics and reporting capabilities for supply chain transformation.
M&A strategies in health industries focus on unlocking value and innovation: dealmakers gear up for a busy second half of 2024.
Competition for innovative technologies will be fierce as dealmaking headwinds begin to subside, accelerating health industries M&A in 2024.
How can quality organisations embrace a patient-centric approach to drive value? To find out where the industry stands on ‘patient-centred quality’, we surveyed and assessed biopharmaceutical and medtech companies’ current approach to quality.
M&A will remain a key transformation tool for health and pharmaceutical companies in the second half of 2023.
GlaxoSmithKline wanted to future-proof their HR function. PwC and Workday worked in collaboration to address the pain points in an employee life-cycle by optimising Workday functions and implementing ServiceNow to support HR services.
Health industries M&A is set to rebound in 2023, with investors attracted by innovation and growth prospects.
Our survey explores the top five challenges facing leading pharma and MedTech companies and highlights recommendations on how they can overcome these impediments.
How quality organisations must evolve to be future-ready.
Heightened PE interest and investments are propelling megadeals in 2021
The growth of digital health solutions has accelerated rapidly in the post-COVID era. But while there are plenty of innovative ideas in development, many companies are still struggling to move beyond promising pilots and into production at scale.
Sustainability should not be seen as a cost that must be offset somewhere else. Manufacturers can turn sustainability into a value differentiator by focusing on three areas.
CEO Andrew Slater describes how the telehealth company has scaled up to meet unprecedented demand while staying true to its mission.
Remote working is here to stay - but with some roles and activities necessitating a physical workplace, what does this mean for the pharma sector?
COVID-19 has highlighted the importance of keeping patients, families, and caregivers informed and connected, and of valuing them as co-creators in building the future of healthcare delivery.
CEO Albert Bourla discusses how a company founded in the 19th century is taking on the biggest health challenges of the 21st century.
New technologies and emerging trends like robotics, artificial intelligence and precision medicine are disrupting the pharmaceutical industry.
How technology can help achieve personalised care for rare disease patients.
Throughout history, epidemics and pandemics have driven profound changes in economic, social and business structures.
The number of life sciences companies raising capital through public offerings has been rising steadily for the past few years.
By 2030, healthcare will be centered on patients empowered to prevent diseases rather than seek treatment.
Senior executives need to lead a workforce that seamlessly blends human talent and automation. Visit strategy+business to read more.